Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R p60 in psoriatic skin is driven by TNF-α

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 2, 2006, Pages 271-278

  Ogilvie, A L J ^a   Luftl M ^a   Antoni, C ^a   Schuler, G ^a   Kalden, J R ^a   Lorenz, H M ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Histochemistry; IL 20; Infliximab; Psoriasis; Therapy; TNF

Indexed keywords

CD15 ANTIGEN; CD3 ANTIGEN; HLA DR ANTIGEN; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 20; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; METHOTREXATE; MONOCLONAL ANTIBODY; PROTEIN P60; PROTEIN P80; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTHRITIS; ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; EPIDERMIS; GRANULOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; KERATINOCYTE; LEUKOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN DEFECT; SKIN DISEASE; TREATMENT RESPONSE;

EID: 33746842257     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900204     Document Type: Article

References (27)

1. Baker H. 1966. Epidemiological aspects of psoriasis and arthritis. Br. J. Dermatol. 78:249.
2. Bos J.D. and M.A. de Rie. 1999. The pathogenesis of psoriasis: immunological facts and speculations. Immunol. Today 20:40.
3. Robert C. and T.S. Kupper. 1999. Inflammatory skin diseases, T cells, and immune surveillance. New Engl. J. Med. 341:1811.
4. Abrams J.R., M.G. Lebwohl, C.A. Guzzo, et al. 1999. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103:1243.
5. Abrams J.R., S.L. Kelley, E. Hayes, T. Kikuchi, M.J. Brown, S. Kang, M. G. Lebwohl, C.A. Guzzo, B.V. Jegasothy, P.S. Linsley and J.G. Krueger. 2000. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J. Exp. Med 192:681.
6. Schlaak J.F., M. Buslau, W. Jochum, E. Hermann, M. Girndt, H. Gallati, K.H. Meyer zum Buschenfelde and B. Fleischer. 1994. T cells involved in psoriasis vulgaris belong to the Th1 subset. J. Invest. Dermatol. 102:145.
7. Leung D.Y., P. Hauk, I. Strickland, J.B. Travers and D.A. Norris. 1998. The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br. J. Dermatol. 139(S): 17.
8. Ettehadi P., M.W. Greaves, D. Wallach, D. Aderka and R.D. Camp. 1994. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin. Exp. Immunol. 96:146.
9. Ogilvie A.L., C. Antoni, C. Dechant, B. Manger, J.R. Kalden, G. Schuler and M. Luftl. 2001. Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate. Br. J. Dermatol. 144:587.
10. Antoni C., C. Dechant, H.M. Lorenz, J. Wendler, A. Ogilvie, M. Lueftl, D. Kalden-Nemeth, J.R. Kalden and B. Manger. 2002. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Rheum. 47:506.
11. Lagoo-Deenadayalan S., A.S. Lagoo, W.H. Barber and K.J. Hardy. 1993. A standardized approach to PCR-based semiquantitation of multiple cytokine gene transcripts from small cell samples. Lymphokine Cytokine Res. 12:59.
12. Rich B.E. and T.S. Kupper. 2001. Cytokines: IL-20 - a new effector in skin inflammation. Curr. Biol. 11:531.
13. Romer J., E. Hasselager, P.L. Norby, T. Steiniche, J. Thorn Clausen and K. Kragballe. 2003. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine A or calcipotriol. J. Invest. Dermatol. 121:1306.
14. Antoni C., C. Dechant, H.-M. Lorenz, A. Ogilvie, D. Kalden-Nemeth, J.R. Kalden and B. Manger. 1999. Successful treatment of severe psoriatic arthritis with infliximab. Arthritis Rheum. 42(S):371.
15. Hwang S.T. 2001. Mechanisms of T-cell homing to skin. Adv. Dermatol. 17:211.
16. Van Oosterhout M., E.W. Levarht, J.K. Sont, T.W. Huizinga, R.E. Toes and J.M. van Laar. 2005. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12. Ann. Rheum. Dis. 64:537.
17. Ulfgren A.K., U. Andersson, M. Engstrom, L. Klareskog, R.N. Maini and P.C. Taylor. 2000. Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis. Arthritis Rheum. 43:2391.
18. Biasi D., A. Carletto, P. Caramaschi, P. Bellavite, T. Maleknia, C. Scambi, N. Favalli and L.M. Bambara. 1998. Neutrophil functions and IL-8 in psoriatic arthritis and in cutaneous psoriasis. Inflammation 22:533.
19. Benoit S., A. Toksoy, E.B. Brocker, R. Gillitzer and M. Goebeler. 2004. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression. Br. J. Dermatol. 150:1009.
20. Konstantinova N.V., D.M. Duong, E. Remenyik, P. Hazarika, A. Chuang and M. Duvic. 1996. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts. J. Invest. Dermatol. 107:615.
21. Debets R., J.P. Hegmans, W.A. Buurman, R. Benner and E.P. Prens. 1996. Expression of cytokines and their receptors by psoriatic fibroblasts. II Decreased TNF receptor expression. Cytokine 8:80.
22. Sticherling M., W. Sautier, J.M. Schroder and E. Christophers. 1999. Interleukin-8 plays its role at local level in psoriasis vulgaris. Acta Derm. Venereol. 79:4.
23. Lemster B.H., P.B. Carroll, H.R. Rilo, N. Johnson, A. Nikaein and A.W. Thomson. 1995. IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. Clin. Exp. Immunol. 99:148.
24. Dumoutier L., C. Leemans, D. Lejeune, S.V. Kotenko and J.C. Renauld. 2001. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. 167:3545.
25. Grone A. 2002. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88:1.
26. Blumberg H., D. Conklin, W.F. Xu, et al. 2001. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104:9.
27. Goedkoop A.Y., M.C. Kraan, D.I. Picavet, M.A. de Rie, M.B. Teunissen, J.D. Bos and P.P. Tak. 2004. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Arthritis Res. Ther. 6:326.